Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2020 $ 3 $ 87,051 $ (83,878) $ (52) $ 3,124
Balance (in Shares) at Dec. 31, 2020 26,859,850        
Issuance of common stock warrants 395 395
Issuance of common stock in connection with exercise of warrants 4 4
Issuance of common stock in connection with exercise of warrants (in Shares) 4,208        
Stock-based compensation expense 384 384
Foreign currency translation adjustment 4 4
Net loss (4,918) (4,918)
Balance at Mar. 31, 2021 $ 3 87,834 (88,796) (48) (1,007)
Balance (in Shares) at Mar. 31, 2021 26,864,058        
Balance at Dec. 31, 2020 $ 3 87,051 (83,878) (52) 3,124
Balance (in Shares) at Dec. 31, 2020 26,859,850        
Net loss         (12,186)
Balance at Sep. 30, 2021 $ 3 89,157 (96,248) (46) (7,134)
Balance (in Shares) at Sep. 30, 2021 27,134,285        
Balance at Mar. 31, 2021 $ 3 87,834 (88,796) (48) (1,007)
Balance (in Shares) at Mar. 31, 2021 26,864,058        
Issuance of common stock to service provider 600 600
Issuance of common stock to service provider (in Shares) 120,000        
Exercise of common stock options 100 100
Exercise of common stock options (in Shares) 126,876        
Stock-based compensation expense 239 239
Foreign currency translation adjustment (1) (1)
Net loss (4,715) (4,715)
Balance at Jun. 30, 2021 $ 3 88,773 (93,511) (49) (4,784)
Balance (in Shares) at Jun. 30, 2021 27,110,934        
Exercise of common stock options 13 13
Exercise of common stock options (in Shares) 23,351        
Stock-based compensation expense 371 371
Foreign currency translation adjustment 3 3
Net loss (2,737) (2,737)
Balance at Sep. 30, 2021 $ 3 89,157 (96,248) (46) (7,134)
Balance (in Shares) at Sep. 30, 2021 27,134,285        
Balance at Dec. 31, 2021 $ 4 125,479 (101,342) (70) 24,071
Balance (in Shares) at Dec. 31, 2021 37,387,472        
Exercise of common stock options 13 13
Exercise of common stock options (in Shares) 24,015        
Stock-based compensation expense 424 424
Foreign currency translation adjustment (9) (9)
Net loss (6,025) (6,025)
Balance at Mar. 31, 2022 $ 4 125,916 (107,367) (79) 18,474
Balance (in Shares) at Mar. 31, 2022 37,411,487        
Balance at Dec. 31, 2021 $ 4 125,479 (101,342) (70) $ 24,071
Balance (in Shares) at Dec. 31, 2021 37,387,472        
Exercise of common stock options (in Shares)         51,602
Net loss         $ (18,850)
Balance at Sep. 30, 2022 $ 4 126,966 (120,192) (327) 6,451
Balance (in Shares) at Sep. 30, 2022 37,432,204        
Balance at Mar. 31, 2022 $ 4 125,916 (107,367) (79) 18,474
Balance (in Shares) at Mar. 31, 2022 37,411,487        
Issuance of common stock warrants 72 72
Exercise of common stock options 6 6
Exercise of common stock options (in Shares) 12,846        
Stock-based compensation expense 491 491
Foreign currency translation adjustment (131) (131)
Net loss (7,335) (7,335)
Balance at Jun. 30, 2022 $ 4 126,485 (114,702) (210) 11,577
Balance (in Shares) at Jun. 30, 2022 37,424,333        
Exercise of common stock options 4 4
Exercise of common stock options (in Shares) 7,871        
Stock-based compensation expense 477 477
Foreign currency translation adjustment (117) (117)
Net loss (5,490) (5,490)
Balance at Sep. 30, 2022 $ 4 $ 126,966 $ (120,192) $ (327) $ 6,451
Balance (in Shares) at Sep. 30, 2022 37,432,204